| Aug 19 |
Mpox test makers end day with huge gains as disease spreads
|
| Aug 19 |
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
|
| Aug 19 |
Mpox vaccine developer Tonix surges 75% following outbreak spread
|
| Aug 19 |
Mpox stocks are on the move as outbreak spreads globally
|
| Aug 19 |
Tonix Pharmaceuticals EPS of -$19.28, revenue of $2.21M misses by $1.37M
|
| Aug 19 |
Tonix Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Highlights
|
| Aug 16 |
Tonix Pharmaceuticals' Live Virus Vaccine Candidate Shows Long-Term Protection From Mpox, Smallpox With 1 Dose, Animal Study Suggests
|
| Aug 16 |
Tonix touts mpox shot's single-dose regimen
|
| Aug 16 |
Tonix Pharmaceuticals Provides Update on the Development of Its Single Dose Live Attenuated Virus Vaccine Candidate for Mpox, TNX-801, as WHO Declares Mpox Outbreak a Global Health Emergency
|
| Aug 13 |
Tonix Pharmaceuticals to Present at the Summer 2024 Virtual Investor Summit
|
